Health
First patient fitted with Carmat artificial heart dies
Publish Date: Mar 04, 2014
First patient fitted with Carmat artificial heart dies
  • mail
  • img
newvision

The first patient fitted with an artificial heart made by the French company Carmat has died, the hospital that had performed the transplant in December said on Monday.

The 76-year-old man died on Sunday, 75 days after the operation, the Georges Pompidou European Hospital in Paris said in a statement, adding that the cause of his death could not be known for sure at this stage.

When he was fitted with the device, the man was suffering from terminal heart failure, when the sick heart can no longer pump enough blood to sustain the body, and was said to have only a few weeks, or even days, to live.

Carmat's bioprosthetic device is designed to replace the real heart for as much as five years, mimicking nature's work using biological materials and sensors. It aims to help the thousands of patients who die each year while awaiting a donor, and reducing the side-effects associated with transplants.

"Carmat wishes to pay tribute to the courage and the pioneering role of this patient and his family, as well as the medical team's dedication," a company spokeswoman said.

She stressed that it was premature to draw any conclusions on Carmat's artificial heart at this stage.

Three more patients in France with terminal heart failure are due to be fitted with the device. The clinical trial will be considered a success if the patients survive with the implant for at least a month.

If it passes the test, Carmat has said it would fit the device into about 20 patients with less severe heart failure. Reuters

 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Singapore launches universal health insurance
Singapore''s parliament has enacted a universal health insurance scheme with nearly $3.0 billion in subsidies to help the elderly and lower-income people....
Using stem cell therapy to treat damaged hearts
A hospital has successfully used stem cells culled from healthy donors to treat seven heart attack victims....
Uproar over genetically modified mosquitoes
A British company''s plan to unleash hordes of genetically modified mosquitoes sparks an outcry from fearful residents....
WHO says Ebola epidemic on the decline
Weekly Ebola infections in west Africa have dropped to below 100 for the first time in more than six months, figures showed Thursday....
Ebola vaccine is safe, researchers say
Preliminary results from a clinical trial on an experimental Ebola vaccine suggest it is safe for use....
Student
A student in Beijing is suing his university after he was allegedly expelled for having the rare hereditary blood disease haemophilia....
Will a ban on Waragi sold in sachets reduce consumption of Alcohol?
Yes
No
Can't Say
follow us
subscribe to our news letter